Literature DB >> 17400055

Structural studies on HLA-G: implications for ligand and receptor binding.

Craig S Clements1, Lars Kjer-Nielsen, James McCluskey, Jamie Rossjohn.   

Abstract

Human leukocyte antigen-G (HLA-G) is a class Ib major histocompatibility complex (MHC) molecule that is specifically expressed in immune-privileged tissues. The overall structure of HLA-G resembles other class I MHC molecules, in which a heavy chain comprised of three domains is noncovalently associated with beta(2)microglobulin (beta(2)m). A nine-residue self-peptide is bound within a cleft formed by two alpha-helices and a beta-sheet floor. An extensive network of contacts is formed between the peptide and the binding cleft, leading to a constrained mode of binding reminiscent of that observed in HLA-E. The alpha3 domain of HLA-G, the putative binding site for leukocyte immunoglobulinlike receptor-1 (LIR-1) and -2, is structurally distinct from class Ia MHC molecules, providing a basis for the observed differences in affinity for these ligands. In addition, a disulfide-bonded dimer adopts an oblique conformation, providing the possibility of a 1:2 (HLA-G dimer:receptor) complex stoichiometry. The relative orientation of the HLA-G protomers in the dimer structure suggests that it is unlikely that dimerization is involved in killer immunoglobulinlike receptor 2DL4 (KIR2DL4) binding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17400055     DOI: 10.1016/j.humimm.2006.09.003

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  22 in total

Review 1.  HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction.

Authors:  Sumati Rajagopalan
Journal:  Cell Mol Immunol       Date:  2014-07-07       Impact factor: 11.530

Review 2.  Primate-specific regulation of natural killer cells.

Authors:  Peter Parham; Laurent Abi-Rached; Lilit Matevosyan; Achim K Moesta; Paul J Norman; Anastazia M Older Aguilar; Lisbeth A Guethlein
Journal:  J Med Primatol       Date:  2010-08       Impact factor: 0.667

3.  The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide.

Authors:  Nicholas G Walpole; Lars Kjer-Nielsen; Lyudmila Kostenko; James McCluskey; Andrew G Brooks; Jamie Rossjohn; Craig S Clements
Journal:  J Mol Biol       Date:  2010-02-01       Impact factor: 5.469

4.  HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet.

Authors:  Federica Grillo; Luca Mastracci; Alessandro Gambella; Stefano Scabini; Gabriele Zoppoli; Annalisa De Silvestri; Simona Pigozzi; Michele Paudice; Michela Campora; Roberto Fiocca
Journal:  Histochem Cell Biol       Date:  2022-07-28       Impact factor: 2.531

Review 5.  Clinical and biological significance of HLA-G expression in ovarian cancer.

Authors:  Jim Jinn-Chyuan Sheu; Ie-Ming Shih
Journal:  Semin Cancer Biol       Date:  2007-07-03       Impact factor: 15.707

6.  Characterization of cynomolgus and vervet monkey placental MHC class I expression: diversity of the nonhuman primate AG locus.

Authors:  Gennadiy I Bondarenko; Svetlana V Dambaeva; Richard L Grendell; Austin L Hughes; Maureen Durning; Mark A Garthwaite; Thaddeus G Golos
Journal:  Immunogenetics       Date:  2009-05-26       Impact factor: 2.846

7.  NetMHCpan, a method for MHC class I binding prediction beyond humans.

Authors:  Ilka Hoof; Bjoern Peters; John Sidney; Lasse Eggers Pedersen; Alessandro Sette; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2008-11-12       Impact factor: 2.846

8.  KIR2DL4 (CD158d): An activation receptor for HLA-G.

Authors:  Sumati Rajagopalan; Eric O Long
Journal:  Front Immunol       Date:  2012-08-20       Impact factor: 7.561

Review 9.  Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.

Authors:  Eduardo A Donadi; Erick C Castelli; Antonio Arnaiz-Villena; Michel Roger; Diego Rey; Philippe Moreau
Journal:  Cell Mol Life Sci       Date:  2010-11-24       Impact factor: 9.261

10.  Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.

Authors:  Anna Gillio-Tos; Maria da Graça Bicalho; Valentina Fiano; Chiara Grasso; Valentina Tarallo; Laura De Marco; Morena Trevisan; Marinabarbaradesousa Xavier; Renata Slowik; Newton S Carvalho; Carlos A Maestri; Hadriano M Lacerda; Daniela Zugna; Lorenzo Richiardi; Franco Merletti
Journal:  BMC Cancer       Date:  2012-12-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.